1 / 3

Fulvestrant injection (5)

Fulvant is an approved prescription medicine. It contains fulvestrant injections of strength 250mg/5ml. This medication helps in treating women with breast cancer. It may show side effects such as difficulty in breathing, hoarseness, cloudy urine, etc. Magicine Pharma has fulvestrant injection on sale at up to 25%.<br>

15032
Download Presentation

Fulvestrant injection (5)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Fulvestrant injection

  2. Overview Fulvant is an approved prescription medicine. It contains fulvestrant injections of strength 250mg/5ml. This medication helps in treating women with breast cancer. It may show side effects such as difficulty in breathing, hoarseness, cloudy urine, etc. Magicine Pharma has fulvestrant injection on sale at up to 25%. Description Fulvant (Fulvestrant) injection is an anti-cancer medication. It is prescribed for the treatment of Breast Cancer (estrogen-dependent) in postmenopausal women. It is available in the form of an injection. Fulvant, comprising Fulvestrant, is a selective estrogen receptor degrader (SERD). It is not recommended for use in breastfeeding. Also, to avoid any further complications, it is necessary to contact a doctor regarding the risks and benefits of taking this injection (before its consumption). Pharmacodynamics Fulvant (Fulvestrant) is an antiestrogen. It acts as an antagonist of the estrogen receptor (ER) and a selective estrogen receptor degrader (SERD). It binds to the estrogen receptor. Fulvant makes it more hydrophobic, further making the receptor unstable and misfold. Therefore, it leads normal processes inside the cell to degrade it. Also, it is an agonist of the G protein-coupled estrogen receptor (GPER), albeit with relatively low affinity (10–100 nM, relative to 3–6 nM for estradiol).

More Related